Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Recent advances in the management of hypertension
A. S. Leon
Kinesiology
Research output
:
Contribution to journal
›
Article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Recent advances in the management of hypertension'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hypertension Management
100%
Recent Advances
100%
Clinical Trials
33%
Primary Prevention
33%
Coronary Artery Disease
33%
Blood Pressure Level
33%
Elevated Blood Pressure
33%
Blood Pressure Lowering
33%
Cardiovascular Mortality
16%
Risk Factors
16%
Quality of Life
16%
Drug Treatment
16%
Factors Affecting Quality
16%
Mortality Rate
16%
Adverse Effects
16%
Patient Characteristics
16%
Public Education
16%
Hypertension Prevention
16%
Professional Education
16%
Antihypertensive Therapy
16%
Essential Hypertension
16%
High-risk Individuals
16%
Adverse Reactions
16%
Medical Conditions
16%
Patients with Hypertension
16%
Antihypertensive Drugs
16%
Individualized Approach
16%
Armamentarium
16%
Blood Pressure Control
16%
Non-pharmacological Methods
16%
Simultaneous Management
16%
Medical Factors
16%
Hypertension and Cardiovascular Disease
16%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Elevated Blood Pressure
100%
Ischemic Heart Disease
100%
Cardiovascular Disease
100%
Observational Study
50%
Antihypertensive Therapy
50%
Drug Treatment of Hypertension
50%
Antihypertensive Drug
50%
Adverse Event
50%
Essential Hypertension
50%
Mortality Rate
50%
Nursing and Health Professions
Blood Pressure
100%
Primary Prevention
66%
Elevated Blood Pressure
66%
Cardiovascular Disease
66%
Ischemic Heart Disease
66%
Quality of Life
33%
Patient with Hypertension
33%
Drug Therapy
33%
Mortality Rate
33%
Antihypertensive Agent
33%
Antihypertensive Therapy
33%
Adverse Event
33%
Essential Hypertension
33%
Pressure Control
33%